Article
Generation of a genome-edited EMILIN1 (c.1606C>T) hiPSC line to investigate aortic aneurysm formation in vitro.
Stem cell research - 1 Aug 2025
Zhang Yanhui, Peitz Michael, Fleischmann Bernd K, Rieck Sarah
Abstract excerpt
Patients with EMILIN1 mutations experience a variety of symptoms, such as the formation of aortic aneurysm (AA) and aortic tortuosity. They suffer from early disease onset and severe disease progression with a higher prevalence in males (Adamo et al. 2022). We generated a homozygous genome-edited human induced pluripotent stem cell (hiPSC) line carrying the EMILIN1 c.1606C>T (p.Gln536*) mutation (EMILIN1 C1606T),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
